These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 17299199)

  • 21. Pharmacological treatment of acute coronary syndromes.
    Hughes K
    Prof Nurse; 2003 Jan; 18(5):296-9. PubMed ID: 12599964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Editor's Roundtable: arterial thrombosis and acute coronary syndromes.
    Friedewald VE; Bates ER; Granger CB; Yusuf S; Roberts WC
    Am J Cardiol; 2007 Sep; 100(6):974-80. PubMed ID: 17826381
    [No Abstract]   [Full Text] [Related]  

  • 23. The year in non-ST-segment elevation acute coronary syndromes.
    Giugliano RP; Braunwald E
    J Am Coll Cardiol; 2005 Sep; 46(5):906-19. PubMed ID: 16139143
    [No Abstract]   [Full Text] [Related]  

  • 24. Platelet glycoprotein IIb/IIIa inhibitor therapy in non-ST segment elevation acute coronary syndromes.
    Elmouchi DA; Bates ER
    Minerva Cardioangiol; 2003 Oct; 51(5):547-60. PubMed ID: 14551523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiplatelet therapy in interventional cardiology: II. Glycoprotein IIb/IIIa inhibitors.
    Jafary FH; Kimmelstiel CD
    J Thromb Thrombolysis; 2000 Feb; 9(2):163-74. PubMed ID: 10613998
    [No Abstract]   [Full Text] [Related]  

  • 26. Platelet glycoprotein IIb/IIIa inhibitors for acute coronary syndromes: initiate treatment early or wait for the catheterization laboratory?
    Harnick DJ; Vorchheimer DA
    Curr Cardiol Rep; 2001 Sep; 3(5):355-61. PubMed ID: 11504571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of glycoprotein IIb/IIIa inhibitors in unstable angina and non-ST-elevation myocardial infarction.
    Crosbie DJ
    Emerg Med Australas; 2005; 17(5-6):500-10. PubMed ID: 16302944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 'I can see clearly now': a new view on the use of IV GP IIb/IIIa inhibitors in acute coronary syndromes.
    Antman EM
    Eur Heart J; 2002 Sep; 23(18):1408-11. PubMed ID: 12208217
    [No Abstract]   [Full Text] [Related]  

  • 29. Role of glycoprotein IIb/IIIa inhibitors in unstable angina: current perspectives.
    Scapa E; Battler A; Hasdai D
    Cardiol Rev; 2000; 8(6):348-53. PubMed ID: 11208255
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of glycoprotein IIb/IIIa inhibition on clinical stabilization parameters in patients with unstable angina and non-Q-wave myocardial infarction.
    Okmen E; Cakmak M; Tartan Z; Cam N
    Heart Vessels; 2003 Jul; 18(3):117-22. PubMed ID: 12955426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycoprotein IIb/IIIa antagonists: do they have a role in the management of unstable angina?
    Redwood S; Marber M; Jackson G
    Int J Clin Pract; 1999 Dec; 53(8):618-22. PubMed ID: 10692757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contemporary view of the acute coronary syndromes.
    Moustapha A; Anderson HV
    J Invasive Cardiol; 2003 Feb; 15(2):71-9. PubMed ID: 12556619
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of platelet glycoprotein IIb/IIIa receptor blockade with tirofiban on adverse cardiac events in women with unstable angina/non-ST-elevation myocardial infarction (PRISM-PLUS Study).
    Huynh T; Theroux P; Snapinn S; Wan Y;
    Am Heart J; 2003 Oct; 146(4):668-73. PubMed ID: 14564321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined antithrombotic therapy for acute coronary syndrome.
    Gawaz M; Müller I; Besta F
    Semin Vasc Med; 2003 May; 3(2):163-76. PubMed ID: 15199479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eptifibatide in acute coronary syndromes.
    Levin T
    N Engl J Med; 1999 Jan; 340(1):60; author reply 61. PubMed ID: 9882213
    [No Abstract]   [Full Text] [Related]  

  • 36. Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes.
    Braunwald E; Maseri A; Armstrong PW; Califf RM; Gibler WB; Hamm CW; Simoons ML; Van de Werf F
    Eur Heart J; 1998 Apr; 19 Suppl D():D22-30. PubMed ID: 9597519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tirofiban in acute coronary syndromes.
    Menozzi A; Merlini PA; Ardissino D
    Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):193-206. PubMed ID: 15853593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet glycoprotein inhibitors in patients with medically managed acute coronary syndrome: does the enthusiasm exceed the science?
    Schriger DL; Herbert ME
    Ann Emerg Med; 2001 Sep; 38(3):249-55. PubMed ID: 11524643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Timing of death and myocardial infarction in patients with non-ST elevation acute coronary syndromes: insights from randomized clinical trials.
    Mehta RH; Greenbaum AB; Lokhnygina Y; Newby LK; Van De Werf F; Armstrong PW; Pieper KS; Califf RM; Granger CB; Harrington RA
    J Interv Cardiol; 2007 Oct; 20(5):299-306. PubMed ID: 17880325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence-based emergency medicine. Use of platelet glycoprotein IIb/IIIa inhibitors in patients with unstable angina and non-ST-segment elevation myocardial infarction.
    Lang ES; Afilalo M
    Ann Emerg Med; 2002 Nov; 40(5):518-20. PubMed ID: 12399796
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.